Date | Title | Description | Source |
28.10.2023 | Roche Teams Up with Ibex and AWS to Advance AI-Powered Digit... | Roche’s navify Digital Pathology software platform now offers Ibex’s Artificial Intelligence (AI) al... | aithority.... |
02.10.2023 | Generative AI start-up Silver Brain AI enters the market wit... |
After operating for two years in stealth, Ankit Garg and Charles Guinand incorporated Silver Brain... | startuptic... |
05.09.2023 | Economist Impact report, Advancing the frontier of health an... | The report shows digital health technologies demonstrate value, yet integrating them into care syste... | en.prnasia... |
27.06.2023 | Nvidia backs Flywheel in $54M round to accelerate medical AI... | Join top executives in San Francisco on July 11-12, to hear how leaders are integrating and optimizi... | venturebea... |
11.05.2023 | Biotech startup DiogenX secures €27.5M to develop therapeuti... | Marseille-based DiogenX, a preclinical-stage biotech company specialising in the development of panc... | siliconcan... |
05.04.2023 | Roche Diagnostics India Unveils #BeYourOwnShero Campaign to ... | Mumbai, Maharashtra, India
Cervical Cancer is India’s second most common cancer, affecting more tha... | newsvoir.c... |
06.01.2023 | The FDA just approved a new Alzheimer's drug that's set to b... | Getty Images
The FDA just approved a new treatment for Alzheimer's disease from Eisai and Biogen. I... | businessin... |
08.12.2022 | Roche Diagnostics Sets New Milestone in the Middle East with... | “Roche” Diagnostics Middle East FZCO has set a new milestone as the first in-vitro diagnostics compa... | aithority.... |
18.11.2022 | Why Top Brands Should Rethink Adaptive Fashion And Take It S... | On the runway at the Double Take adaptive fashion show on September 8 2022IMAXTree for Genentech
Fa... | forbes.com... |
15.11.2022 | Zest wants to make buying and sending gifts online ‘delightf... | While e-commerce was on the rise before the pandemic, the massive shift to digital supercharged the ... | techcrunch... |
14.11.2022 | A top Wall Street analyst names 6 major events that could se... | Medical samples in vacutainer tubes held by a laboratory technician. Matthew Horwood/Getty Images Th... | businessin... |
04.11.2022 | Roche introduces the navify brand for its digital health sol... | Roche unifies its digital health portfolio under the navify brand, providing a range of next generat... | en.prnasia... |
04.11.2022 | Roche introduces the navify brand for its digital health sol... | Roche unifies its digital health portfolio under the navify brand, providing a range of next generat... | einpresswi... |
24.10.2022 | Roche receives FDA clearance for COVID-19 PCR test for use o... | The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automat... | globenewsw... |
19.10.2022 | Roche to present new OCREVUS (ocrelizumab) data in multiple ... | OCREVUS data will show significant benefit on slowing disease activity and progression in patients w... | globenewsw... |
12.10.2022 | Positive new data for Roche’s Evrysdi in largest trial ever ... | New two-year Evrysdi data show improvement or maintenance of motor function in people with SMA, a pr... | globenewsw... |
12.10.2022 | Roche to introduce its next-generation portfolio of SARS-CoV... | Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performa... | globenewsw... |
11.10.2022 | Roche launches PRAME (EPR20330) Antibody to identify PRAME p... | The PRAME (EPR20330) Antibody evaluates PRAME protein expression from patients with suspected melano... | globenewsw... |
05.10.2022 | Roche to present new data from its expanding neuromuscular d... | New positive data from Evrysdi, a treatment for spinal muscular atrophy (SMA), a progressive neuromu... | globenewsw... |
04.10.2022 | Roche receives FDA approval for first companion diagnostic t... | Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2. T... | globenewsw... |
03.10.2022 | Roche hires new diagnostics chief from within, ahead of ... | More than two months after Severin Schwan announced he’s leaving Roche and handing the reins to... | endpts.com... |
28.09.2022 | The success of Biogen's new Alzheimer's drug could be the st... | A Biogen employee works in the company's lab in Cambridge, Massachusetts in 2013. Suzanne Kreiter/Th... | businessin... |
20.09.2022 | Healthcare Trends: Life Sciences Companies Are Becoming Supp... | Assume our business is always about the patient. That was how Michael Schmidt, co-founder and execut... | forbes.com... |
19.09.2022 | Biogen and Eisai's latest clinical trial is inching towards ... | A Biogen employee works in the company's lab in Cambridge, Massachusetts in 2013. Suzanne Kreiter/Th... | businessin... |
19.09.2022 | European Commission approves Roche’s Vabysmo, the first bisp... | Phase III data that showed people with nAMD and DME treated with Vabysmo up to every four months ach... | globenewsw... |
23.08.2022 | Roche launches a digital PCR system, a powerful new diagnost... | The Digital LightCycler System is a next-generation digital PCR system that helps clinical researche... | globenewsw... |
16.08.2022 | FDA accepts supplemental Biologics License Application for R... | First new treatment regimen in more than 20 years to significantly improve outcomes in people with t... | globenewsw... |
15.08.2022 | Roche launches new diagnostic test for the better understand... | Elecsys IGRA SARS-CoV-2 test supports the better understanding of immune response to SARS-CoV-2 infe... | globenewsw... |
12.08.2022 | Roche announces U.S. FDA approval of Xofluza to treat influe... | Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approve... | globenewsw... |
29.07.2022 | Bristol Myers' combo hits a roadblock in PhIII kidney... | Bristol Myers Squibb has hit a snag in its Phase III trial investigating the company’s Opd... | endpts.com... |
22.07.2022 | CHMP recommends EU approval of Roche’s Vabysmo, the first bi... | Vabysmo (faricimab) simultaneously targets and inhibits two disease pathways that drive neovascular ... | globenewsw... |
21.07.2022 | Roche appointed Thomas Schinecker as new Roche CEO | Roche announced that the Board of Directors has appointed Thomas Schinecker as new Roche CEO effecti... | bio-m.org/... |
19.07.2022 | Roche's Elecsys Amyloid Plasma Panel granted FDA Breakthroug... | The Elecsys Amyloid Plasma Panel is intended to be used in conjunction with other clinical informati... | globenewsw... |
18.07.2022 | Roche launches innovative dual antigen and antibody diagnost... | Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and ind... | globenewsw... |
14.07.2022 | New two-year data confirm Roche’s Vabysmo improves vision wi... | In the TENAYA and LUCERNE studies, more than 60% of Vabysmo patients could be treated every four mon... | globenewsw... |
11.07.2022 | Two years after scrapping three hemophilia trials, No... | Novo Nordisk continues to move forward with its once-daily monoclonal antibody for hemop... | endpts.com... |
11.07.2022 | New data from phase III HAVEN 6 study reinforce favourable s... | Hemlibra continues to demonstrate clinically meaningful bleed control, with 66.7% of participants wi... | globenewsw... |
06.07.2022 | FDA grants Priority Review to Roche’s Lunsumio for people wi... | Lunsumio® (mosunetuzumab) could be the first CD20xCD3 T-cell engaging bispecific antibody approved b... | globenewsw... |
28.06.2022 | Roche launches the VENTANA DP 600 slide scanner for digital ... | The VENTANA DP 600 is Roche’s new, high-capacity slide scanner that creates high-resolution, digital... | globenewsw... |
16.06.2022 | Roche’s Failed Alzheimer’s Trial Could Have Implications for... | Roche Holding announced on Thursday that a trial aimed at preventing Alzheimer’s disease had failed.... | barrons.co... |
16.06.2022 | Roche launches human papillomavirus (HPV) self-sampling solu... | Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,00... | globenewsw... |
15.06.2022 | Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first P... | The cobas SARS-CoV-2 Duo test combines the standard qualitative result of a traditional SARS-CoV-2 P... | globenewsw... |
10.06.2022 | Roche announces positive data from broad blood cancer portfo... | Long-term data at the European Hematology Association (EHA) 2022 congress expands understanding of t... | globenewsw... |
09.06.2022 | European Commission approves Roche’s Tecentriq as adjuvant t... | In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or deat... | globenewsw... |
31.05.2022 | FDA approves Roche’s Evrysdi for use in babies under two mon... | Approval based on interim RAINBOWFISH data which show pre-symptomatic babies treated with Evrysdi fo... | globenewsw... |
27.05.2022 | New pivotal data demonstrate clinical benefit of Roche’s glo... | Data to be presented for the first time at ASCO and EHA 2022 show glofitamab induces high and durabl... | globenewsw... |
25.05.2022 | Roche’s Polivy combination approved by European Commission f... | First new treatment option in more than 20 years to show a clinically meaningful improvement in prog... | globenewsw... |
12.05.2022 | Roche enters partnership with the Global Fund to support low... | Almost half of the world’s population has no or limited access to diagnosticsThis situation is espec... | globenewsw... |
11.05.2022 | [Ad hoc announcement pursuant to Art. 53 LR] Roche reports i... | The SKYSCRAPER-01 study evaluating tiragolumab plus Tecentriq did not meet its co-primary endpoint o... | globenewsw... |
11.05.2022 | New Roche Cancer Data Slams Biopharma Stocks | Disappointing results from a Roche Holding trial of an experimental cancer drug called tiragolumab a... | barrons.co... |
29.04.2022 | New three-year data for Roche’s Evrysdi (risdiplam) show lon... | 91% of infants treated with Evrysdi in the FIREFISH study were still alive at three years Infants tr... | globenewsw... |
22.04.2022 | CHMP recommends EU approval of Roche’s Tecentriq as adjuvant... | In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or deat... | globenewsw... |
22.04.2022 | CHMP recommends EU conditional approval of Roche’s potential... | If approved, mosunetuzumab would be the first CD20xCD3 T-cell engaging bispecific antibody available... | globenewsw... |
04.04.2022 | U.S. FDA grants priority review to Roche’s Actemra/RoActemra... | If approved, Actemra/RoActemra would be the first U.S. FDA-approved immunomodulator for the treatmen... | globenewsw... |
30.03.2022 | Ad hoc announcement pursuant to Art. 53 LR Roche provides up... | Ad hoc announcement pursuant to Art. 53 LR
Roche provides update on phase III SKYSCRAPER-02 study i... | globenewsw... |
25.03.2022 | Roche to present data across broad and impactful neuroscienc... | First data showing OCREVUS treatment effect on disability progression in non-active secondary progre... | globenewsw... |
25.03.2022 | CHMP recommends EU approval of Roche’s Polivy combination fo... | Polivy plus R-CHP showed first clinically meaningful improvement in PFS with comparable safety in pe... | globenewsw... |
23.03.2022 | Roche donates additional medicines and diagnostics for Ukrai... | Basel, 23 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the donation of additional... | globenewsw... |
16.03.2022 | New data for Roche’s Evrysdi (risdiplam) demonstrate long-te... | Long-term efficacy data from the pivotal SUNFISH study confirm increases in motor function are susta... | globenewsw... |
16.03.2022 | Roche provides molecular testing solutions to identify and d... | Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the ... | globenewsw... |
14.03.2022 | Roche Diagnostics India Earns the Frost & Sullivan 2021 ... | Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faste... | en.prnasia... |
08.03.2022 | Roche to present new Evrysdi data at MDA 2022 and highlight ... | Evrysdi® (risdiplam) data further confirm long-term efficacy and safety data in a broad range of peo... | globenewsw... |
02.03.2022 | Alliance for Artificial Intelligence in Healthcare Elects Ne... | “AI will continue to have a demonstrable impact on human health. Having spent the last three years i... | prweb.com/... |
11.02.2022 | WHO grants prequalification of Actemra/RoActemra for patient... | WHO’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoAc... | globenewsw... |
11.02.2022 | New two-year data for Roche’s Vabysmo and Susvimo reinforce ... | In the YOSEMITE and RHINE studies in diabetic macular edema, at least 60% of eligible Vabysmo patien... | globenewsw... |
09.02.2022 | Quest Diagnostics Incorporated : Media Statement about COVID... | This is an evolving situation. Please check back to this page periodically for the latest informatio... | marketscre... |
07.02.2022 | Endeavor snags $101M to go after Boehringer, Roche in lung s... | Endeavor Biomedicines wants to best the two idiopathic pulmonary fibrosis (IPF) drugs on the market ... | fiercebiot... |
07.02.2022 | Endeavor snags $101M to go after Boehringer, Roche in lung s... | Endeavor Biomedicines wants to best the two idiopathic pulmonary fibrosis (IPF) drugs on the market ... | fiercebiot... |
03.02.2022 | Chugai Pharmaceutical : F. Hoffmann-La Roche Announces Finan... | February 3, 2022
Name of listed company: Chugai Pharmaceutical Co., Ltd.
Code number:
4519 (1st S... | marketscre... |
31.01.2022 | FDA approves Roche’s Vabysmo, the first bispecific antibody ... | Vabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive neovascular or “wet” a... | globenewsw... |
24.01.2022 | Chugai's Actemra Approved for Additional Indication of SARS-... | TOKYO - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that it obtained regulatory approval... | marketscre... |
24.01.2022 | The Lancet publishes studies showing Roche’s faricimab impro... | Two papers in The Lancet highlight one-year results from Roche’s phase III trials evaluating faricim... | globenewsw... |
21.01.2022 | Chugai Pharmaceutical : Actemra Approved for Additional Indi... | Chugai's Actemra Approved for Additional Indication of
SARS-CoV-2 Pneumonia in Japan
The approval ... | marketscre... |
12.01.2022 | Large companies leverage startup blockchain technologies |
Cwm Taf Morgannwg University Health Board (CTMUHB) of NHS Wales, Roche Diagnostics, Digipharm and ... | startuptic... |
12.01.2022 | Roche launches the cobas® pulse system, an industry first pr... | Roche launches the cobas® pulse system, an industry first professional blood glucose management solu... | globenewsw... |
12.01.2022 | Roche launches the cobas® pulse system, an industry first pr... | Roche launches the cobas® pulse system, an industry first professional blood glucose management solu... | marketscre... |
12.01.2022 | Quest Diagnostics Incorporated : Media Statement about COVID... | This is an evolving situation. Please check back to this page periodically for the latest informatio... | marketscre... |
11.01.2022 | Roche introduces cobas infinity edge, a new open digital eco... | Roche’s new cloud-based platform connects patient test results, medical records and third-party appl... | globenewsw... |
05.01.2022 | Quest Diagnostics Incorporated : Media Statement about COVID... | This is an evolving situation. Please check back to this page periodically for the latest informatio... | marketscre... |
27.12.2021 | Biotech investor Brad Loncar shares 10 predictions for 2022,... | Brad Loncar, a biotech investor and the CEO of Loncar Investments. Brad Loncar This story is availab... | businessin... |
24.12.2021 | Roche COVID-19 At-Home Test granted FDA Emergency Use Author... | Rapid test to support the American public’s fight against the COVID-19 pandemic, with availability t... | globenewsw... |
22.12.2021 | Quest Diagnostics Incorporated : Media Statement about COVID... | This is an evolving situation. Please check back to this page periodically for the latest informatio... | marketscre... |
15.12.2021 | Roche launches the first infectious disease tests and cobas ... | PLEASANTON, Calif., Dec. 15, 2021 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced... | marketscre... |
14.12.2021 | Roche’s Polivy combination reduced the risk of disease worse... | Polivy plus R-CHP is the first treatment regimen to significantly improve outcomes in previously unt... | globenewsw... |
13.12.2021 | Roche launches the AVENIO Edge System to simplify and automa... | Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to spec... | globenewsw... |
13.12.2021 | Interim data from phase III HAVEN 6 study demonstrate favour... | People with moderate or mild haemophilia A have significant unmet clinical needs, as this population... | globenewsw... |
13.12.2021 | Chugai Pharmaceutical : Files for Additional Indication of A... | Chugai Files for Additional Indication of Actemra for COVID-19
Pneumonia in Japan
Application was ... | marketscre... |
13.12.2021 | Roche launches the AVENIO Edge System to simplify and automa... | Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to spec... | marketscre... |
11.12.2021 | Roche presents pivotal data at ASH 2021 for novel cancer imm... | Results to be presented for the first time show mosunetuzumab induces high and durable complete resp... | globenewsw... |
10.12.2021 | New data from the phase II CITYSCAPE trial show encouraging ... | After 2.5 years median follow-up, pre-planned exploratory analyses in the PD-L1-high population show... | globenewsw... |
10.12.2021 | Roche : Phase II study of Roche's giredestrant meets primary... | Investor Update Phase II study of Roche's giredestrant meets primary endpoint in the most frequently... | marketscre... |
10.12.2021 | Flagship on center stage: Axcella’s new CMO likens the b... | Margaret Koziel
Margaret Koziel has bounced back and forth between academia and biotech throug... | endpts.com... |
09.12.2021 | Quest Diagnostics Incorporated : Media Statement about COVID... | This is an evolving situation. Please check back to this page periodically for the latest informatio... | marketscre... |
08.12.2021 | Chugai Pharmaceutical : Actemra/RoActemra Approved by the Eu... | Chugai's Actemra/RoActemra Approved by the European Commission
to Treat Patients with Severe COVID-... | marketscre... |
07.12.2021 | Chugai Pharmaceutical : CHMP Recommends EU Approval of Chuga... | CHMP Recommends EU Approval of Chugai's Actemra/RoActemra to
Treat Patients with Severe COVID-19
A... | marketscre... |
07.12.2021 | Actemra/RoActemra approved by the European Commission to tre... | EMA’s CHMP recommended the approval yesterday
Approval based on results from four phase III studies ... | globenewsw... |
06.12.2021 | Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test ... | Roche announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional... | aithority.... |
06.12.2021 | CHMP recommends EU approval of Actemra/RoActemra to treat pa... | Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a revi... | globenewsw... |
06.12.2021 | Roche has Rapidly Developed Additional Testing Options to Di... | Roche and TIB Molbiol, a newly acquired subsidiary within the Roche Diagnostics division, have added... | aithority.... |
06.12.2021 | Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test ... | The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A... | marketscre... |